Position in CTXR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,798
-$1,365 QoQ
Shares Held
4,626
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 43 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in CTXR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $1,741,341 across 4 Biotechnology names. CTXR ranks #4 (0.2% of the industry book) .
All Filings in CTXR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,798 | 4,626 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,163 | 4,626 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,594 | 4,626 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $5,736 | 4,626 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $7,355 | 4,626 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $6,892 | 4,626 | Shares | Sole | 2025-05-22 | |
| 2024-09-30 | $140,931 | 281,300 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $149,679 | 256,300 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $72,926 | 81,300 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $61,544 | 81,300 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $55,609 | 81,300 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $97,560 | 81,300 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $95,121 | 81,300 | Shares | Sole | 2023-05-19 | |
| No filing history on record for this holder in this stock. | ||||||